Bob Blouin, PharmD
Executive Vice Chancellor, UNC-Chapel Hill
Dr. Robert A. “Bob” Blouin serves as the provost, Chief Academic Officer and Chief Operating Officer of the university.
|
John Bamforth, PhD
Director, Eshelman Institute for Innovation at UNC Eshelman School of Pharmacy, UNC-Chapel Hill
Dr. John Bamforth oversees efforts to accelerate the creation and development of new medicines and technologies.
|
Angela Kashuba, PharmD
Dean, UNC Eshelman School of Pharmacy, John and Deborah McNeill, Jr. Distinguished Professor
Dr. Angela Kashuba serves as director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry
|
Penny Gordon-Larsen, PhD
Associate Dean for Research, UNC Gillings School of Global Public Health
Dr. Gordon-Larsen provides intellectual and strategic leadership and vision for research programs at the UNC Gillings School of Public Health.
|
Blossom Damania, PhD
Vice Dean for Research, UNC School of Medicine, Boshamer Distinguished Professor, Microbiology and Immunology Dr. Blossom Damania oversees the research enterprise at the UNC School of Medicine, which brings in over $500 million in annual research funding. |
Terry Magnuson, PhD
Kay M. & Van L. Weatherspoon Eminent Distinguished Professor, UNC Department of Genetics, UNC Vice Chancellor for Research
Dr. Terry Magnuson is the founding chair of the UNC Department of Genetics. He oversees, develops and supports UNC-Chapel Hill’s $1 billion research enterprise. |
Ralph Baric, PhD
(Founder) William R. Kenan, Jr. Distinguished Professor, Department of Epidemiology, Department of Microbiology and Immunology, UNC-Chapel Hill
Dr. Ralph S. Baric has spent the past three decades as a world leader in the study of coronaviruses and is responsible for UNC-Chapel Hill’s world leadership in coronavirus research. |
Nat Moorman, PhD
(Founder) Associate Professor, UNC School of Microbiology and Immunology
Dr. Nat Moorman is a founding member of READDI. His research includes studying how viruses hijack cellular machinery to facilitate their replication. |
Mark Heise, PhD
(Founder) Professor, Department of Genetics at the UNC School of Medicine
Dr. Mark Heise is a founding member of READDI. He researches how viral and host genetic factors interact to influence the pathogenesis of virus-induced disease. |
John Bamforth, PhD
Interim Executive Director |
Roy Zwahlen, JD
Interim Associate Director of Operations |
Kelly Collins
Interim Lead Development Officer |
Bob Dieterle
Interim Chief Technology Officer |
Sumitra Pati, PhD
Interim Strategic and Competitive Intelligence |
Ashlie Thomas
Interim Project Manager |
Ryan McDaniel
Interim Website Administrator |
READDI is led by The University of North Carolina at Chapel Hill.
|